Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data
J
Jonah D. Garry
(Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN.)
E
Evan L. Brittain
Article Details
Journal
Circulation
Volume / Issue
Vol. 153, Issue 13
Published
March 31, 2026
Pages
980-982
ISSN
0009-7322
Publisher
Lippincott Williams & Wilkins
Authors (2)
J
Jonah D. Garry
Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN.
E
Evan L. Brittain
Related Articles from this Journal
Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations
Johanna Mueller-Leisse, Henrike Aenne Katrin Hillmann et al.
Aug 2026
10.1161/circulationaha.126.080556
Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Albert J. Rogers, Sabyasachi Bandyopadhyay et al.
Aug 2026
10.1161/circulationaha.126.080755
Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>
Jennifer E. Ho, Ryan J. Tedford
Aug 2026
10.1161/circulationaha.126.080205
ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction
Yu Liu, Yijin Chen et al.
Aug 2026
10.1161/circulationaha.125.078593
Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Dong Li, Shuang Zhang et al.
Aug 2026
10.1161/circulationaha.126.079996